SIGA — SIGA Technologies, Inc.

SIGA closed at $3.20 (+1.43%) on Oct 27, 2026. Float: 40.5M shares. Latest SEC filing: 10-Q on Aug 6, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for SIGA in the TickerWise workspace.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

Company profile

• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic
• Country: US
• Exchange: NASDAQ
• Employees: 46
• Website: https://www.siga.com

Latest SEC filings for SIGA

• 2026-08-0610-Q
• 2026-08-068-K
• 2026-06-25S-8
• 2026-06-108-K
• 2026-05-0710-Q
• 2026-05-078-K
• 2026-03-268-K
• 2026-03-108-K
• 2026-03-1010-K
• 2025-11-0610-Q

Latest SIGA news

• 2026-10-28SIGA secures $15M contract from Canadian Department of National Defence Read article

Related companies

• TAK — Takeda Pharmaceutical Company Limited
• ZTS — Zoetis Inc.
• TEVA — Teva Pharmaceutical Industries Limited
• HLN — Haleon plc
• VTRS — Viatris Inc.
• NBIX — Neurocrine Biosciences, Inc.
• RDY — Dr. Reddy's Laboratories Limited
• ELAN — Elanco Animal Health Incorporated

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.